person

Jeremy D. C.

Country
France
Department
Pédiatrie

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
0
Sites with multiple studies

Has run more than one trial at 0 of 5 partner sites.

Specializations

Hereditary Transthyretin Amyloidosis

Investigation of disease mechanisms and therapeutic strategies for hereditary transthyretin amyloidosis affecting peripheral nerves and the heart.

  • ATTRv polyneuropathy
  • ATTR cardiomyopathy
  • TTR gene silencing therapies
  • Stabilizer molecules for transthyretin

Emphasis on early diagnosis and disease‑modifying interventions in adult and pediatric populations.

Genetic Liver Metabolic Disorders

Clinical studies targeting inherited disorders of hepatic metabolism such as alpha‑1 antitrypsin deficiency and glycogen storage disease type II.

  • Alpha‑1 antitrypsin deficiency liver disease
  • Glycogen storage disease management
  • Hereditary angioedema hepatic involvement
  • Metabolic liver disease biomarkers

Integration of genotype‑driven treatment pathways within the pediatric setting.

Pediatric Metabolic Liver Disease and Transplantation

Focus on severe metabolic liver conditions in children and outcomes of liver transplantation.

  • Neonatal cholestasis
  • Metabolic liver failure in infants
  • Liver transplant eligibility criteria
  • Post‑transplant graft function monitoring

Collaborative care across the two affiliated research sites enhances longitudinal patient tracking.

Rare Neuromuscular and Mitochondrial Disorders

Exploration of neuromuscular diseases linked to metabolic dysfunction, including Friedreich ataxia and mitochondrial DNA mutations.

  • Friedreich ataxia cardiac involvement
  • Mitochondrial myopathy therapies
  • Myotonic dystrophy metabolic aspects
  • Peripheral neuropathy in metabolic disorders

Multidisciplinary assessment bridges neurology and hepatology expertise.

Autoimmune and Inflammatory Hepatic Conditions

Clinical evaluation of immune‑mediated liver diseases such as primary biliary cholangitis and autoimmune hepatitis.

  • Primary biliary cholangitis treatment response
  • Autoimmune hepatitis immunosuppression strategies
  • Systemic lupus erythematosus hepatic manifestations
  • Inflammatory hepatic vasculitis

Research aligns with broader autoimmune disease programs within the institution.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.